title: Cytokine induction by extracellular products of oral viridans group streptococci.
abstract: During an etiological study of Kawasaki disease (mucocutaneous lymph node syndrome [MCLS]), we found that dominant viridans streptococcal strains on tooth surfaces and in the throat of both MCLS patients and non-MCLS control children formed erythrogenic and biologically active, extracellular products. In this study, we demonstrated that erythrogenic culture supernatant concentrates of representative strains (two Streptococcus mitis and two Streptococcus oralis), when injected intravenously, induced serum tumor necrosis factor alpha, interleukin-6 (IL-6), and gamma interferon in muramyldipeptide- or Propionibacterium acnes-primed C3H/HeN mice. The concentrates also induced tumor necrosis factor alpha, IL-6, and thymocyte-activating factor (essentially IL-1) in murine peritoneal macrophage, human monocyte, and human whole-blood cultures. An erythrogenic, heat-labile extracellular protein fraction (F-1) that was concentrated from the culture supernatants of a representative S. mitis strain exhibited the above-mentioned cytokine-inducing activity. This partially purified F-1 fraction also induced thymocyte-activating factor and IL-6 in human umbilical vascular endothelial cell and gingival fibroblast cultures.
authors.affiliation: Department of Microbiology and Immunology, Kagoshima University Dental School, Japan.
authors.forename: H
authors.initials: H
authors.lastname: Takada
authors.forename: Y
authors.initials: Y
authors.lastname: Kawabata
authors.forename: M
authors.initials: M
authors.lastname: Tamura
authors.forename: K
authors.initials: K
authors.lastname: Matsushita
authors.forename: H
authors.initials: H
authors.lastname: Igarashi
authors.forename: H
authors.initials: H
authors.lastname: Ohkuni
authors.forename: Y
authors.initials: Y
authors.lastname: Todome
authors.forename: T
authors.initials: T
authors.lastname: Uchiyama
authors.forename: S
authors.initials: S
authors.lastname: Kotani
mesh_terms: D000818:Animals; D001427:Bacterial Toxins / Q000302:isolation & purification / Q000494:pharmacology; D002478:Cells, Cultured; D016207:Cytokines / Q000096:biosynthesis* / Q000097:blood; D004730:Endothelium, Vascular / Q000276:immunology; D005098:Exotoxins / Q000302:isolation & purification / Q000494:pharmacology; D005881:Gingiva / Q000276:immunology; D006801:Humans; D066298:In Vitro Techniques; D007223:Infant; D008264:Macrophages / Q000276:immunology; D008297:Male; D051379:Mice; D008809:Mice, Inbred C3H; D009000:Monocytes / Q000276:immunology; D009055:Mouth / Q000382:microbiology; D009080:Mucocutaneous Lymph Node Syndrome / Q000209:etiology / Q000276:immunology* / Q000382:microbiology*; D011817:Rabbits; D013291:Streptococcus / Q000276:immunology* / Q000302:isolation & purification
chemical_list: D001427:Bacterial Toxins; D016207:Cytokines; D005098:Exotoxins